It has been shown that the inhibition of NF-κB results in the inhibition of fos expression and consequently the AP-1 activity in pancreatic adenocarcinoma cell lines (MDApanc-28) [39]. The gene discussed is FOS; the disease is pancreatic adenocarcinoma.